Ecstasy-for-Medicine Advocate Raises $100 Million

[ad_1] The Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, has raised more than $100 million in a Series A private stock sale.   MAPS needed…

WSJ News Exclusive | Ecstasy-for-Medicine Advocate MAPS Looks for Cash Lifeline

[ad_1] MAPS, a nonprofit, is working on an $85 million private share sale to keep itself afloat until mid-2024, when it hopes to start selling MDMA in the U.S. [ad_2]…